STOCK TITAN

Iron Horse (IROH) Financials

IROH
FY2024 annual
Revenue Not reported for FY2024
Net Income $1.4M +545.5% YoY
EPS (Diluted) Not reported for FY2024
Operating Cash Flow -$1.0M -1117.5% YoY
Source SEC Filings (10-K/10-Q) Latest period Q1 FY2026, ended Mar 31, 2026 Reported Currency USD FYE December

Newest figures come from the 10-Q for Q1 FY2026, filed May 13, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the IROH SEC filings page.

This page shows Iron Horse (IROH) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 3 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI IROH FY2024

Financing-led balance sheet dominates, with reported profit disconnected from operating cash generation.

FY2024's $1.4M net income coexisted with a -$1.7M operating loss and operating cash flow of -$1.0M, so the headline profit was not produced by operations. The combination makes earnings quality the central issue: accounting profit and cash generation moved in opposite directions.

From FY2023 to FY2024, liabilities fell from $69.7M to $39.9M while equity rose from $1 to $10.8M; that shift materially changed the balance-sheet posture even as assets contracted from $69.7M to $50.8M. The current ratio also improved from 0.8x to 1.1x, moving from a short-term asset shortfall to a modest excess over current liabilities.

FY2023's $69.0M investing outflow was nearly offset by a $69.7M financing inflow, while FY2024's investing outflow was only $226K and financing inflow $583K. That contrast indicates the earlier balance-sheet scale-up was funded externally rather than by internally generated operations, making capital structure more informative than revenue-based analysis here.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Financial health score not available

Iron Horse does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.

Piotroski F-Score Partial
3/6

Iron Horse passes 3 of 6 computable financial strength tests (3 of the nine could not be computed from available data). 2 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass.

Earnings Quality No Cash Backing

For every $1 of reported earnings, Iron Horse used $0.74 of operating cash (-$1.0M OCF vs $1.4M net income). Earnings that no cash stands behind rest on accounting accruals, which cannot be repeated indefinitely.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$5.8M
YoY+20.8%

Iron Horse generated $5.8M in revenue in Q1 2026. This represents an increase of 20.8% from the same quarter a year earlier.

EBITDA
$842K
YoY-1.8%

Iron Horse's EBITDA was $842K in Q1 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 1.8% from the same quarter a year earlier.

Net Income
-$309K
YoY-139.9%

Iron Horse reported -$309K in net income in Q1 2026. This represents a decrease of 139.9% from the same quarter a year earlier.

EPS (Diluted)
-$0.01

Iron Horse earned -$0.01 per diluted share (EPS) in Q1 2026.

Cash & Balance Sheet

Free Cash Flow
-$3.6M
YoY-1408.3%

Iron Horse recorded an outflow of $3.6M in free cash flow in Q1 2026, representing a cash shortfall after capex. This represents a decrease of 1408.3% from the same quarter a year earlier.

Cash & Debt
$29.7M
YoY+33739519.3%
QoQ-10.1%

Iron Horse held $29.7M in cash as of Q1 2026; long-term debt is not reported for that period.

Shares Outstanding
52M
QoQ0.0%

Iron Horse had 52M shares outstanding in Q1 2026. It is unchanged from the prior quarter.

Dividends Per Share

Not reported for Q1 2026.

Margins & Returns

Gross Margin
74.9%
YoY+26.0pp

Iron Horse's gross margin was 74.9% in Q1 2026, indicating the percentage of revenue retained after direct costs. This is up 26.0 percentage points from the same quarter a year earlier.

Operating Margin
12.5%
YoY-4.1pp

Iron Horse's operating margin was 12.5% in Q1 2026, reflecting core business profitability. This is down 4.1 percentage points from the same quarter a year earlier.

Net Margin
-5.3%
YoY-21.3pp

Iron Horse's net profit margin was -5.3% in Q1 2026, showing the share of revenue converted to profit. This is down 21.3 percentage points from the same quarter a year earlier.

Return on Equity
-1.6%
YoY-8.2pp

Iron Horse's ROE was -1.6% in Q1 2026, measuring profit generated per dollar of shareholder equity. This is down 8.2 percentage points from the same quarter a year earlier.

Capital Allocation

R&D Spending
$38K
YoY+39.6%

Iron Horse invested $38K in research and development in Q1 2026. This represents an increase of 39.6% from the same quarter a year earlier.

Capital Expenditures
$2K
YoY-97.9%

Iron Horse invested $2K in capex in Q1 2026, funding long-term assets and infrastructure. This represents a decrease of 97.9% from the same quarter a year earlier.

Share Buybacks

Not reported for Q1 2026.

IROH Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

IROH quarterly income statement
MetricQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-QQ3'2410-QQ2'2410-Q
Revenue$5.8M+20.8%N/A$7.9M+84.2%N/A$4.8MN/A$4.3MN/A
Cost of Revenue$1.5M-40.6%N/A$2.3M+73.9%N/A$2.5MN/A$1.3MN/A
Gross Profit$4.4M+85.2%N/A$5.6M+88.8%N/A$2.4MN/A$2.9MN/A
R&D Expenses$38K+39.6%N/A$38KN/A$27KN/AN/AN/A
SG&A Expenses$3.1M+637.5%N/A$438K-13.9%N/A$416KN/A$509KN/A
Operating Income$731K-9.3%N/A$4.6M+99.5%-$672K-181.7%$805K+267.8%N/A$2.3M+1775.3%-$238K-295.2%
EBITDA$842K-1.8%N/AN/AN/A$857KN/AN/AN/A
Interest Expense$206KN/A-$10K-11.0%N/AN/AN/A-$9KN/A
Income Tax$851K+579.8%N/A$1.4M+85.3%$146K-17.9%$125K-40.7%N/A$744K$178K
Net Income-$309K-139.9%N/A$3.3M+113.5%$2.9M+718.9%$774K+206215.5%N/A$1.6M+1242.7%$357K+691.6%
EPS (Basic)-$0.01-136.4%N/A$0.07+75.0%N/A$0.02N/A$0.04N/A
EPS (Diluted)-$0.01N/A$0.07N/A$0.02N/A$0.04N/A
Diluted Shares (Avg)52MN/A48MN/A48MN/A48MN/A

IROH Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

IROH quarterly balance sheet
MetricQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-QQ3'2410-QQ2'2410-Q
Total Assets$39.1M-46.9%$44.7M-11.9%$56.2M-21.6%$73.3M+3.3%$73.6M+4.6%$50.8M-27.2%$71.8M$71.0M
Current Assets$31.4M+39258.1%$36.9M-16.2%$46.2M+64669.6%$155K-35.3%$80K-85.4%$44.0M+6278.1%$71K$239K
Cash & Equivalents$29.7M+33739519.3%$33.0M-20.3%$37.2M+1206361.5%$25K-72.5%$88-100.0%$41.4M+6206.6%$3K$91K
Inventory$851K$956K-23.5%$1.9MN/AN/A$1.3MN/AN/A
Accounts ReceivableN/A$287-66.0%$0N/AN/A$845N/AN/A
Total Liabilities$19.2M-69.0%$24.9M-37.8%$38.5M-38.6%$75.0M+17.6%$62.0M-2.3%$39.9M-42.7%$62.6M$63.7M
Current Liabilities$19.0M+466.5%$24.6M-38.4%$38.2M+2413.5%$72.4M+5891.9%$3.4M+206.2%$39.9M+4535.6%$1.5M$1.2M
Non-Current Liabilities$186K-99.7%$243K$298K-99.5%$2.5M-96.0%$58.7M-6.0%$0-100.0%$61.1M$62.5M
Total Equity$19.9M+71.0%$19.9M+83.8%$17.7M+94.6%$14.7M+103.1%$11.6M+67.8%$10.8M+1081058700.0%$9.1M+2010.4%$7.3M+2233.1%
Retained Earnings$12.1M+349.4%$12.4M+210.5%$11.0M+440.6%-$6.1M-103.8%-$4.9M-72.4%$4.0M+248.5%-$3.2M-$3.0M

Not reported in any period shown, so not listed: Short-Term Investments, Long-Term Investments, Goodwill, Long-Term Debt.

IROH Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

IROH quarterly cash flow statement
MetricQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-QQ3'2410-QQ2'2410-Q
Operating Cash Flow-$3.6M-2076.3%N/A-$3.7M-116.4%-$1.9M-3463.0%-$165K+55.8%-$22.9M$22.3M-$53K
Depreciation & Amortization$111K+114.2%N/AN/AN/A$52KN/AN/AN/A
Capital Expenditures$2K-97.9%N/AN/AN/A$73KN/AN/AN/A
Free Cash Flow-$3.6M-1408.3%N/AN/AN/A-$239KN/AN/AN/A
Investing Cash Flow-$2K+97.8%N/A-$1.7M+38.9%$1.2M+116815400.0%-$75K-2355.3%$2.6M-$2.8M$1
Financing Cash Flow$116K-75.4%N/A$35K$510K+1557.8%$471K+540.6%$725K$0-$35K

Not reported in any period shown, so not listed: Stock-Based Compensation, Dividends Paid, Share Buybacks.

IROH Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

IROH quarterly financial ratios
MetricQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-QQ3'2410-QQ2'2410-Q
Gross Margin74.9%+26.0ppN/A70.4%+1.7ppN/A48.9%N/A68.7%N/A
Operating Margin12.5%-4.1ppN/A58.0%+4.5ppN/A16.7%N/A53.5%N/A
Net Margin-5.3%-21.3ppN/A42.3%+5.8ppN/A16.0%N/A36.5%N/A
Return on Equity-1.6%-8.2ppN/A18.9%+1.7pp19.8%+14.9pp6.7%+6.6ppN/A17.2%4.9%
Return on Assets-0.8%-1.8ppN/A5.9%+3.8pp4.0%+3.5pp1.1%+1.1ppN/A2.2%0.5%
Current Ratio1.65+1.6x1.50+0.4x1.21+1.2x0.00-0.2x0.02-0.5x1.10+0.3x0.050.20
Debt-to-Equity0.97-4.4x1.25-2.4x2.17-4.7x5.09-3.7x5.33-3.8x3.69-999996.3x6.878.78
Asset Turnover0.15+0.1xN/A0.14+0.1xN/A0.07N/A0.06N/A
FCF Margin-61.8%-56.8ppN/AN/AN/A-5.0%N/AN/AN/A

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company Fiscal year Revenue Net income Net margin Market cap Health score
Iron Horse IROH FY2024 N/A $1.4M N/A $20.8M
DT Cloud Acquisition DYCQ FY2024 N/A $2.3M N/A $32.4M
Bayview Acqsn BAYA FY2025 N/A $203K N/A $33.2M
Quetta Acquisition QETA FY2025 $5.0M $323K 6.5% $44.0M 22/100
Bowen Acquisition Corp BOWN FY2024 N/A $3.0M N/A $27.7M
Melar Acquisition Corp. I MACIW FY2025 N/A $5.5M N/A N/A

Frequently Asked Questions

Is Iron Horse profitable?

Yes, Iron Horse (IROH) reported a net income of $1.4M in fiscal year 2024.

What is Iron Horse's return on equity (ROE)?

Iron Horse (IROH) has a return on equity of 12.7% for fiscal year 2024, measuring how efficiently the company generates profit from shareholder equity.

What is Iron Horse's operating cash flow?

Iron Horse (IROH) recorded an outflow of $1.0M in operating cash flow during fiscal year 2024, representing cash used by core business activities.

Iron Horse (IROH) had $50.8M in total assets as of fiscal year 2024, including both current and long-term assets.

Iron Horse (IROH) had 48M shares outstanding as of fiscal year 2024.

Iron Horse (IROH) had a current ratio of 1.10 as of fiscal year 2024, which is considered adequate.

Iron Horse (IROH) had a debt-to-equity ratio of 3.69 as of fiscal year 2024, measuring the company's financial leverage by comparing total debt to shareholder equity.

Iron Horse (IROH) had a return on assets of 2.7% for fiscal year 2024, measuring how efficiently the company uses its assets to generate profit.

Iron Horse (IROH) has a Piotroski F-Score of 3 out of 6 computable signals; 3 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

For every $1 of reported earnings, Iron Horse (IROH) used $0.74 of operating cash (-$1.0M OCF vs $1.4M net income). Earnings that no cash stands behind rest on accounting accruals, which cannot be repeated indefinitely. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Back to top